Continuous glucose monitoring (CGM) has the potential to revolutionize diabetes management during pregnancy by providing detailed and real-time data to patients and clinicians, overcoming many of the limitations of self-monitoring of blood glucose. Although there are limited data on the role of CGM to improve pregnancy outcomes in patients with type 2 diabetes or gestational diabetes, CGM has been shown to reduce pregnancy complications in patients with type 1 diabetes. Despite the limited data in some populations, given its ease of use and recent U.S. Food and Drug Administration approval with expanding insurance coverage, CGM has gained widespread popularity among pregnant patients with all types of diabetes. It is critical for obstetric clinicians to understand how CGM can be successfully integrated into clinical practice. We present a practical, step-wise approach to CGM data interpretation that can be incorporated into diabetes management during pregnancy and common CGM pitfalls and solutions. Although technology will continue to advance with newer-generation CGM devices and diabetes technology such as automated insulin delivery (not covered here), these key principles form a basic foundation for understanding CGM technology and its utility for pregnant people.

中文翻译：

---

妊娠期糖尿病管理的连续血糖监测：证据、实用技巧和常见陷阱。


连续血糖监测 （CGM） 通过向患者和临床医生提供详细和实时的数据，克服自我监测血糖的许多限制，有可能彻底改变怀孕期间的糖尿病管理。尽管关于 CGM 对改善 2 型糖尿病或妊娠糖尿病患者妊娠结局的作用的数据有限，但 CGM 已被证明可以减少 1 型糖尿病患者的妊娠并发症。尽管某些人群的数据有限，但鉴于其易用性以及最近美国食品和药物管理局批准扩大保险范围，CGM 在患有各种类型糖尿病的孕妇中广受欢迎。产科临床医生了解如何将 CGM 成功整合到临床实践中至关重要。我们提出了一种实用的、循序渐进的 CGM 数据解释方法，可以将其纳入怀孕期间的糖尿病管理以及常见的 CGM 陷阱和解决方案。尽管技术将继续随着新一代 CGM 设备和糖尿病技术（如自动胰岛素输送）而进步（此处未涵盖），但这些关键原则构成了理解 CGM 技术及其对孕妇的效用的基本基础。